Cargando…
减低剂量预处理单倍型外周血造血干细胞移植治疗50岁以上恶性血液肿瘤患者的临床研究
OBJECTIVE: To analyze the efficacy of HLA-haploidentical peripheral hematopoietic stem cell transplantation (haplo-PBSCT) following reduced intensity conditioning (RIC) regimen to treat the patients with hematological malignancies who were older than 50 years old. METHODS: Eighteen patients with hem...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342871/ https://www.ncbi.nlm.nih.gov/pubmed/31495134 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.08.008 |
Ejemplares similares
-
恶性血液病单倍型造血干细胞移植预处理中兔抗人胸腺细胞球蛋白剂量优化探讨
Publicado: (2020) -
单倍型造血干细胞移植治疗非恶性血液病研究进展
Publicado: (2018) -
低剂量抗胸腺细胞球蛋白在供、受者年龄均≥40岁恶性血液病同胞相合外周血干细胞移植中的应用
Publicado: (2018) -
清髓剂量预处理异基因造血干细胞移植治疗年龄≥55岁高危恶性血液系统疾病12例临床分析
Publicado: (2016) -
减低剂量环磷酰胺的预处理方案对重型再生障碍性贫血同胞全相合外周血造血干细胞移植疗效的影响
Publicado: (2017)